全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Biological Effects of Phosphate on Fibroblast-Like Synoviocytes

DOI: 10.5402/2012/295341

Full-Text   Cite this paper   Add to My Lib

Abstract:

This study sought to examine the expression of genes implicated in phosphate transport and pathological calcification in osteoarthritis (OA) and rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and investigate the biological effects of phosphate. Results revealed that several genes, which were implicated in phosphate transport and pathological calcification, were differentially expressed in OA FLS and RA FLS. Phosphate stimulated the expression of matrix metalloproteinse-1, matrix metalloproteinse-3, cyclooxygenase-2, and interleukin-1β in a dose-dependent manner. Phosphate also induced OA FLS cell death but not RA FLS cell death at higher concentration. Calcification inhibitors, phosphocitrate (PC), and ethane-1-hydroxy-1,1-diphosphonate (EHDP), effectively inhibited these detrimental biological effects of phosphate. These findings suggest that abnormal expression of genes implicated in phosphate transport and pathological calcification may contribute to the progression of OA through the induction of extracellular matrix-degrading enzymes, proinflammatory cytokines, cell death, and calcium deposits. Calcification inhibitors such as PC and EHDP are potent inhibitors of these detrimental biological effects of phosphate. 1. Introduction Osteoarthritis (OA) is characterized by the degeneration of articular cartilage. Although the precise biochemical events that initiates OA are not well understood, many risk or contributory factors have been identified including aging, obesity, and pathological calcification. Basic calcium phosphate (BCP) and calcium pyrophosphate dihydrate (CPPD) crystals are the two most common forms of articular calcium phosphate crystals. These crystals are found in the synovial fluid of the patients with OA, and their presence in the synovial fluid correlates with the radiographic evidence of cartilaginous degeneration [1–3]. Calcium phosphate crystals were also found in the synovial fluid of up to 26% of the patients with rheumatoid arthritis (RA), and a worse clinical outcome was associated with the presence of these crystals [4]. BCP and CPPD crystals stimulate the expression of matrix metalloproteinases (MMPs), mitogenesis, and endocytotic activity of cells in monolayer culture [5, 6]. These crystals may also alter the biomechanical properties of menisci and articular cartilage [7]. Recently, Cheung et al. demonstrated that calcium phosphocitrate (CaPC), a potent calcification inhibitor, reduced the degeneration of articular cartilage in Hartley guinea pig [8]. Their study has provided support for the hypothesis that

References

[1]  G. J. Carroll, R. A. Stuart, J. A. Armstrong, P. D. Breidahl, and B. A. Laing, “Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1β,” Journal of Rheumatology, vol. 18, no. 6, pp. 861–866, 1991.
[2]  B. A. Derfus, J. B. Kurian, J. J. Butler et al., “The high prevalence of pathologic calcium crystals in pre-operative knees,” Journal of Rheumatology, vol. 29, no. 3, pp. 570–574, 2002.
[3]  S. Nalbant, J. A. M. Martinez, T. Kitumnuaypong, G. Clayburne, M. Sieck, and H. R. Schumacher Jr, “Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies,” Osteoarthritis and Cartilage, vol. 11, no. 1, pp. 50–54, 2003.
[4]  J. C. Gerster, P. A. Varisco, J. Kern, J. Dudler, and A. K. L. So, “CPPD crystal deposition disease in patients with rheumatoid arthritis,” Clinical Rheumatology, vol. 25, no. 4, pp. 468–469, 2006.
[5]  G. M. McCarthy, P. G. Mitchell, and H. S. Cheung, “The mitogenic response to stimulation with basic calcium phosphate crystals is accompanied by induction and secretion of collagenase in human fibroblasts,” Arthritis and Rheumatism, vol. 34, no. 8, pp. 1021–1030, 1991.
[6]  Y. Sun, X. R. Zeng, L. Wenger, and H. S. Cheung, “Basic calcium phosphate crystals stimulate the endocytotic activity of cells—inhibition by anti-calcification agents,” Biochemical and Biophysical Research Communications, vol. 312, no. 4, pp. 1053–1059, 2003.
[7]  Y. Sun, D. R. Mauerhan, P. R. Honeycutt et al., “Calcium deposition in osteoarthritic menisci and meniscal cell culture,” Arthritis Research & Therapy, vol. 12, no. 2, p. R56, 2010.
[8]  H. S. Cheung, J. D. Sallis, K. D. Demadis, and A. Wierzbicki, “Phosphocitrate blocks calcification-induced articular joint degeneration in a guinea pig model,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2452–2461, 2006.
[9]  P. B. Halverson, A. Greene, and H. S. Cheung, “Intracellular calcium responses to basic calcium phosphate crystals in fibroblasts,” Osteoarthritis and Cartilage, vol. 6, no. 5, pp. 324–329, 1998.
[10]  D. Wang, L. Canaff, D. Davidson et al., “Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes,” Journal of Biological Chemistry, vol. 276, no. 36, pp. 33995–34005, 2001.
[11]  K. Mansfield, R. Rajpurohit, and I. M. Shapiro, “Extracellular phosphate lions cause apoptosis of terminally differentiated epiphyseal chondrocytes,” Journal of Cellular Physiology, vol. 179, no. 3, pp. 276–286, 1999.
[12]  D. Magne, G. Bluteau, C. Faucheux et al., “Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification,” Journal of Bone and Mineral Research, vol. 18, no. 8, pp. 1430–1442, 2003.
[13]  H. S. Cheung and D. J. McCarty, “Mechanisms of connective tissue damage by crystals containing calcium,” Rheumatic Disease Clinics of North America, vol. 14, no. 2, pp. 365–376, 1988.
[14]  Y. Sun, G. S. Firestein, L. Wenger, C. Y. C. Huang, and H. S. Cheung, “Telomerase-transduced osteoarthritic fibroblast-like synoviocyte cell line,” Biochemical and Biophysical Research Communications, vol. 323, no. 4, pp. 1287–1292, 2004.
[15]  Y. Sun, G. Firestein, D. Boyle, H. Gruber, and H. Cheung, “Longterm culture of telomerase-transduced rheumatoid arthritis fibroblast-like synoviocytes display a distinct gene expression pattern,” Journal of Rheumatology, vol. 34, no. 10, pp. 1959–1970, 2007.
[16]  Y. Sun, D. R. Mauerhan, G. S. Firestein, B. J. Loeffler, E. N. Hanley, and H. E. Gruber, “Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile,” Journal of Rheumatology, vol. 36, no. 1, pp. 141–155, 2009.
[17]  V. V. Kunjathoor, M. Febbraio, E. A. Podrez et al., “Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages,” Journal of Biological Chemistry, vol. 277, no. 51, pp. 49982–49988, 2002.
[18]  K. Takahashi, M. Takeya, and N. Sakashita, “Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals,” Medical Electron Microscopy, vol. 35, no. 4, pp. 179–203, 2002.
[19]  C. J. Williams, A. Pendleton, G. Bonavita et al., “Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease,” Arthritis and Rheumatism, vol. 48, no. 9, pp. 2627–2631, 2003.
[20]  L. Hessle, K. A. Johnson, H. C. Anderson et al., “Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 14, pp. 9445–9449, 2002.
[21]  D. Harmey, L. Hessle, S. Narisawa, K. A. Johnson, R. Terkeltaub, and J. L. Millán, “Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank: an integrated model of the pathogenesis of mineralization disorders,” American Journal of Pathology, vol. 164, no. 4, pp. 1199–1209, 2004.
[22]  K. Johnson, K. Pritzker, J. Goding, and R. Terkeltaub, “The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles,” Journal of Rheumatology, vol. 28, no. 12, pp. 2681–2691, 2001.
[23]  K. Johnson, S. Hashimoto, M. Lotz, K. Pritzker, J. Goding, and R. Terkeltaub, “Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification,” Arthritis and Rheumatism, vol. 44, no. 5, pp. 1071–1081, 2001.
[24]  L. M. Ryan and A. K. Rosenthal, “Metabolism of extracellular pyrophosphate,” Current Opinion in Rheumatology, vol. 15, no. 3, pp. 311–314, 2003.
[25]  H. C. Anderson, J. B. Sipe, L. Hessle, R. Dhanyamraju, E. Atti, and N. P. Camacho, “Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice.[erratum appears in Am J Pathol. 12004 May;164(5):873 Note: Dhamyamraju, Rama [corrected to Dhanyamraju, Rama]],” American Journal of Pathology, vol. 164, no. 3, pp. 841–847, 2004.
[26]  G. M. McCarthy, P. R. Westfall, I. Masuda, P. A. Christopherson, H. S. Cheung, and P. G. Mitchell, “Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes,” Annals of the Rheumatic Diseases, vol. 60, no. 4, pp. 399–406, 2001.
[27]  M. P. Morgan, L. C. Whelan, J. D. Sallis, C. J. McCarthy, D. J. Fitzgerald, and G. M. McCarthy, “Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1β,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1642–1649, 2004.
[28]  X. R. Zeng, Y. Sun, L. Wenger, and H. S. Cheung, “Induction of early growth response gene Egr2 by basic calcium phosphate crystals through a calcium-dependent protein kinase C-independent p44/42 mitogen-activated protein kinase pathway,” Cells Tissues Organs, vol. 174, no. 1-2, pp. 63–72, 2003.
[29]  Y. Sun, P. Reuben, L. Wenger, J. D. Sallis, K. D. Demadis, and H. S. Cheung, “Inhibition of calcium phosphate-DNA coprecipitates induced cell death by phosphocitrates,” Frontiers in Bioscience, vol. 10, pp. 803–808, 2005.
[30]  E. Takeda, Y. Taketani, N. Sawada, T. Sato, and H. Yamamoto, “The regulation and function of phosphate in the human body,” BioFactors, vol. 21, no. 1–4, pp. 345–355, 2004.
[31]  E. Takeda, Y. Taketani, K. Nashiki et al., “A novel function of phosphate-mediated intracellular signal transduction pathways,” Advances in Enzyme Regulation, vol. 46, no. 1, pp. 154–161, 2006.
[32]  X. R. Zeng, Y. Sun, L. Wenger, and H. S. Cheung, “Basic calcium phosphate crystal-induced Egr-1 expression stimulates mitogenesis in human fibroblasts,” Biochemical and Biophysical Research Communications, vol. 330, no. 3, pp. 658–664, 2005.
[33]  F. L. Wang, J. R. Connor, R. A. Dodds et al., “Differential expression of Egr-1 in osteoarthritic compared to normal adult human articular cartilage,” Osteoarthritis and Cartilage, vol. 8, no. 3, pp. 161–169, 2000.
[34]  D. Nair, R. P. Misra, J. D. Sallis, and H. S. Cheung, “Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway,” Journal of Biological Chemistry, vol. 272, no. 30, pp. 18920–18925, 1997.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133